- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.2: 8 residues within 4Å:- Chain A: A.441, S.444, L.445, W.472, I.477, L.481
- Chain D: F.596
- Ligands: PTY.1
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:L.445, D:F.596
- Hydrogen bonds: A:W.472
POV.8: 8 residues within 4Å:- Chain A: F.596
- Chain B: A.441, S.444, L.445, W.472, I.477, L.481
- Ligands: PTY.7
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.596, B:L.445
- Hydrogen bonds: B:W.472
POV.14: 8 residues within 4Å:- Chain B: F.596
- Chain C: A.441, S.444, L.445, W.472, I.477, L.481
- Ligands: PTY.13
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:L.445, B:F.596
- Hydrogen bonds: C:W.472
POV.20: 8 residues within 4Å:- Chain C: F.596
- Chain D: A.441, S.444, L.445, W.472, I.477, L.481
- Ligands: PTY.19
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:L.445, C:F.596
- Hydrogen bonds: D:W.472
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.3: 13 residues within 4Å:- Chain A: W.315, Y.316, F.364, T.371, L.375, L.493, L.496, F.497, A.499, N.500
- Chain D: F.522, L.526, L.529
10 PLIP interactions:7 interactions with chain A, 3 interactions with chain D- Hydrophobic interactions: A:T.371, A:L.375, A:L.493, A:F.497, A:F.497, D:F.522, D:L.526, D:L.529
- Hydrogen bonds: A:Y.316, A:N.500
Y01.9: 13 residues within 4Å:- Chain A: F.522, L.526, L.529
- Chain B: W.315, Y.316, F.364, T.371, L.375, L.493, L.496, F.497, A.499, N.500
10 PLIP interactions:7 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:T.371, B:L.375, B:L.493, B:F.497, B:F.497, A:F.522, A:L.526, A:L.529
- Hydrogen bonds: B:Y.316, B:N.500
Y01.15: 13 residues within 4Å:- Chain B: F.522, L.526, L.529
- Chain C: W.315, Y.316, F.364, T.371, L.375, L.493, L.496, F.497, A.499, N.500
10 PLIP interactions:3 interactions with chain B, 7 interactions with chain C- Hydrophobic interactions: B:F.522, B:L.526, B:L.529, C:T.371, C:L.375, C:L.493, C:F.497, C:F.497
- Hydrogen bonds: C:Y.316, C:N.500
Y01.21: 13 residues within 4Å:- Chain C: F.522, L.526, L.529
- Chain D: W.315, Y.316, F.364, T.371, L.375, L.493, L.496, F.497, A.499, N.500
10 PLIP interactions:3 interactions with chain C, 7 interactions with chain D- Hydrophobic interactions: C:F.522, C:L.526, C:L.529, D:T.371, D:L.375, D:L.493, D:F.497, D:F.497
- Hydrogen bonds: D:Y.316, D:N.500
- 4 x ZN: ZINC ION(Non-covalent)
ZN.4: 4 residues within 4Å:- Chain A: H.172, C.176, C.178, C.181
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.172, A:C.176, A:C.178, A:C.181
ZN.10: 4 residues within 4Å:- Chain B: H.172, C.176, C.178, C.181
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:H.172, B:C.176, B:C.178, B:C.181
ZN.16: 4 residues within 4Å:- Chain C: H.172, C.176, C.178, C.181
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:H.172, C:C.176, C:C.178, C:C.181
ZN.22: 4 residues within 4Å:- Chain D: H.172, C.176, C.178, C.181
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:H.172, D:C.176, D:C.178, D:C.181
- 4 x CA: CALCIUM ION(Non-covalent)
CA.5: 5 residues within 4Å:- Chain A: E.418, E.421, N.436, D.439, R.492
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:E.418, A:D.439
CA.11: 5 residues within 4Å:- Chain B: E.418, E.421, N.436, D.439, R.492
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:E.418, B:D.439
CA.17: 5 residues within 4Å:- Chain C: E.418, E.421, N.436, D.439, R.492
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:E.418, C:D.439
CA.23: 5 residues within 4Å:- Chain D: E.418, E.421, N.436, D.439, R.492
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:E.418, D:D.439
- 4 x YZY: (2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
YZY.6: 12 residues within 4Å:- Chain A: L.521, Y.524, L.528, Q.573, F.576, W.577
- Chain D: F.599, V.610, I.611, V.614, V.615
- Ligands: PTY.1
11 PLIP interactions:7 interactions with chain A, 4 interactions with chain D- Hydrophobic interactions: A:L.521, A:Y.524, A:L.528, A:F.576, A:F.576, D:V.610, D:I.611, D:V.614, D:V.615
- Hydrogen bonds: A:Q.573, A:W.577
YZY.12: 12 residues within 4Å:- Chain A: F.599, V.610, I.611, V.614, V.615
- Chain B: L.521, Y.524, L.528, Q.573, F.576, W.577
- Ligands: PTY.7
11 PLIP interactions:7 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:L.521, B:Y.524, B:L.528, B:F.576, B:F.576, A:V.610, A:I.611, A:V.614, A:V.615
- Hydrogen bonds: B:Q.573, B:W.577
YZY.18: 12 residues within 4Å:- Chain B: F.599, V.610, I.611, V.614, V.615
- Chain C: L.521, Y.524, L.528, Q.573, F.576, W.577
- Ligands: PTY.13
11 PLIP interactions:7 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:L.521, C:Y.524, C:L.528, C:F.576, C:F.576, B:V.610, B:I.611, B:V.614, B:V.615
- Hydrogen bonds: C:Q.573, C:W.577
YZY.24: 12 residues within 4Å:- Chain C: F.599, V.610, I.611, V.614, V.615
- Chain D: L.521, Y.524, L.528, Q.573, F.576, W.577
- Ligands: PTY.19
11 PLIP interactions:4 interactions with chain C, 7 interactions with chain D- Hydrophobic interactions: C:V.610, C:I.611, C:V.614, C:V.615, D:L.521, D:Y.524, D:L.528, D:F.576, D:F.576
- Hydrogen bonds: D:Q.573, D:W.577
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, K. et al., Structural basis for human TRPC5 channel inhibition by two distinct inhibitors. Elife (2021)
- Release Date
- 2021-03-31
- Peptides
- Short transient receptor potential channel 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x YZY: (2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, K. et al., Structural basis for human TRPC5 channel inhibition by two distinct inhibitors. Elife (2021)
- Release Date
- 2021-03-31
- Peptides
- Short transient receptor potential channel 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.